6月14日 Yubin Zhou:A STIMulating journey into CRACking the calcium entry code——from structure to therapeutics to optogenetic engineering(生命科学系列学术报告)

  

报告人简介:

Dr. Yubin Zhou is currently a tenured associate professor and American Cancer Society Research Scholar at the Center for Translational Cancer Research, Institute of Biosciences & Technology at Texas A&M University. He is also a joint faculty in the Department of Medical Physiology, College of Medicine at Texas A&M University. Dr. Zhou received his medical training from Zhejiang University School of Medicine in 2003. Dr. Zhou earned his M.S. degree in Chemistry (2007) and Ph.D. degree in Biochemistry (2008) from Georgia State University. He received his postdoctoral training at Harvard Medical School (2008-2010) and then worked as an instructor at La Jolla Institute for Immunology (2010-2012). Dr. Zhou is the recipient of the prestigious Leukemia & Lymphoma Society Fellow Award (2008), Special Fellow Award (2011), the Research Excellence Award at TAMU-COM (2017), the ACS Research Scholar Award (2017), and the John S. Dunn Foundation Research Award. He also serves as an Associate Editor for Current Molecular Medicine and sits in the editorial boards of Molecular and Cellular Biology and Scientific Reports. Dr. Zhou has published nearly 100 papers and holds four US patents related to cancer diagnostics and therapeutics, with some licensed to biotech companies for exploring clinical applications. His research interests focus on i) discovering novel ion channels that control cancer cell growth and anti-tumor immunity; ii) devising innovative tools for noninvasive intervention of cancer cell signaling and genome engineering; iii) developing new generations of intelligent cell-based anticancer immunotherapy; and iv) designing better treatment strategies for autoimmune diseases and cancer. Dr. Zhou’s recent work in calcium channels, anticancer drug screening, optogenetics and cancer immunotherapy was published/highlighted by top-tier journals (e.g., Nature Cell Biology, Nature Communications, Nature Structural and Molecular Biology, JACS, PNAS, and eLife), and featured in multiple media outlets including NIH’s Biomedical Beats Blog, the American Chemical Society, and the Royal Society of Chemistry. His ongoing research is supported by multiple grants from the National Institutes of Health (NIGMS and NCI), the Welch Foundation, the John S. Dun Foundation, the Department of Defense, the Cancer Prevention & Research Institute of Texas and the American Cancer Society.